Goldman Sachs’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $290M | Buy |
|
|||||
|
2022
Q2 | $11.8M | Buy |
|
|||||
|
2022
Q1 | $9.68M | Sell |
|
|||||
|
2021
Q4 | $19.6M | Buy |
|
|||||
|
2021
Q3 | $2.2M | Sell |
|
|||||
|
2021
Q2 | $3.18M | Sell |
|
|||||
|
2021
Q1 | $30.7M | Sell |
|
|||||
|
2020
Q4 | $45.8M | Buy |
|
|||||
|
2020
Q3 | $25.9M | Sell |
|
|||||
|
2020
Q2 | $28M | Buy |
|
|||||
|
2020
Q1 | $8.83M | Sell |
|
|||||
|
2019
Q4 | $11.3M | Buy |
|
|||||
|
2019
Q3 | $496K | Sell |
|
|||||
|
2019
Q2 | $827K | Sell |
|
|||||
|
2019
Q1 | $2.68M | Sell |
|
|||||
|
2018
Q4 | $2.35M | Sell |
|
|||||
|
2018
Q3 | $2.76M | Sell |
|
|||||
|
2018
Q2 | $2.9M | Buy |
|
|||||
|
2018
Q1 | $2.75M | Sell |
|
|||||
|
2017
Q4 | $1.59M | Buy |
|
|||||
|
2017
Q3 | $1.64M | Buy |
|
|||||
|
2017
Q2 | $687K | Sell |
|
|||||
|
2017
Q1 | $577K | Buy |
|
|||||
|
2016
Q4 | $432K | Buy |
|
|||||
|
2016
Q3 | $215K | Sell |
|
|||||
|
2016
Q2 | $253K | Sell |
|
|||||
|
2016
Q1 | $166K | Buy |
|
|||||
|
2015
Q4 | $157K | Buy |
|
|||||
|
2015
Q3 | $103K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $1M | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $99K | Buy |
|